Status:
COMPLETED
Speech, Linguistic and Acoustic Markers in Parkinson's Disease
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
Boston University
VA Puget Sound Health Care System
Conditions:
Parkinson Disease
Cognitive Impairment, Mild
Eligibility:
All Genders
18+ years
Brief Summary
The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer spe...
Eligibility Criteria
Inclusion
- Parkinson's Disease (or healthy control)
- Disease duration ≥ 2 years
- Mild cognitive impairment or normal cognition
Exclusion
- Diagnosis of dementia (MoCA \<21)
- Adults unable to consent
- Age \< 18
- Pregnant women
- Prisoners
- Non-English speakers
- Any neurological disorder other than PD
- Deep brain stimulator placement
- Severe, unstable psychiatric disorder
- Unintelligible speech due to effects of PD
- Visual acuity or color vision impairment that would interfere with cognitive testing
- Other voice, speech or swallowing disorders or history of surgery involving palate/nasopharynx/larynx/vocal cords
Key Trial Info
Start Date :
January 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2025
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04273672
Start Date
January 13 2020
End Date
February 28 2025
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMass Medical School/UMass Memorial Medical Center
Worcester, Massachusetts, United States, 01655